Filing Flows

Filing Flows › Clover Health Investments (CLOV) › Next earnings date

Clover Health Investments (CLOV) earnings: beat the estimate

Clover Health Investments (CLOV) reported on Nov 4, 2026 and beat the EPS estimate: $0.03 against $0.01 (+177.0%). Revenue was $759M for Q3 2026, +53% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+177.0% vs estimate
Beat rate80%

The last report

Clover Health Investments reported revenue of $759M for the third quarter 2026 (+53% Y/Y), net earnings $6.4M. How it makes money → · Every quarter →

Clover Health Investments: EPS against the estimate, last 5 reportsClover Health Investments: EPS against the estimate, last 5 reportsEstimateReported$0.02$0.00Nov 25−$0.05−$0.05Feb 26$0.07$0.07May 26$0.05$0.07Aug 26$0.01$0.03Nov 26
Latest (Nov 26): Estimate $0.01, Reported $0.03.

Clover Health Investments' latest quarter

Clover Health Investments, Q3 2026: revenue $759M (+53% year over year), operating margin 0.8%, net earnings $6.4M, operating cash flow $70.4M. The chart follows the revenue to costs, profit and cash.

Questions

Did Clover Health Investments beat earnings?

Clover Health Investments (CLOV) reported on Nov 4, 2026 and beat the EPS estimate: $0.03 against $0.01 (+177.0%).

When does CLOV report earnings?

The next date is not set yet.

Does Clover Health Investments usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.